Budget Impact Test

News

UK pharma concedes defeat on NHS drug cost controls

After its request for a legal review was thrown out yesterday, UK pharma industry association the ABPI has confirmed it won’t appeal the decision.

News

NHS supremo hails Alexion and Roche deals, but defends budge...

Feelings are running high in the UK pharmaceutical industry at the moment, with fears about a new NHS drugs budget squeeze and Brexit causing major concerns.

Views & Analysis

Ultra-rare disease drugs: has access in England just got har...

New rules on market access introduced by NICE from 1 April will affect most new medicines – but gaining access to ultra-orphan drugs could become much more difficult.

Views & Analysis

Pharma could take NHS England to court over new delaying tac...

Pharma and patient groups are dismayed by new cost-capping and delaying measures, which they say will further restrict access to new medicines in England.

News